Targeted Intraoperative Radiotherapy Is a Safe Approach for Patients with Pacemakers: A Case Study and Literature Review
Autor: | Alexandra Grubnik, Dennis R. Holmes, Carol-Ann Benn, Yasmin Mayat, Yastira Ramdas |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
medicine.medical_treatment Sentinel lymph node Population Case Report lcsh:RC254-282 cardiac implantable electronic device breast cancer Breast cancer Biopsy medicine education Device failure Intraoperative radiation therapy education.field_of_study targeted intraoperative radiotherapy medicine.diagnostic_test business.industry Wide local excision lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens medicine.disease pacemaker Oncology Radiology intraoperative radiation therapy business Intraoperative radiotherapy |
Zdroj: | Case Reports in Oncology, Vol 13, Iss 2, Pp 916-922 (2020) Case Reports in Oncology |
ISSN: | 1662-6575 |
DOI: | 10.1159/000508946 |
Popis: | Case reports detailing the effects of targeted intraoperative radiation therapy (IORT) on patients with cardiac pacemakers (PMs) are rare. This growing population sub-group requiring IORT and lack of standardized guidelines necessitate more practical published research. An 81-year-old patient with clinical stage II, T1 N0 grade III, triple-negative invasive ductal carcinoma and an implanted single-lead chamber PM (VVIR mode, model: Biotronik, type Effecta SR) received targeted intraoperative radiotherapy at the time of wide local excision and sentinel lymph node biopsy. It presents the shortest distance between the outer diameter of the PM and IORT applicator in literature. Target IORT was performed utilizing an Intrabeam device (50 kV, Carl Zeiss Surgical, Oberkochen, Germany). This case elucidates the successful use of targeted IORT for breast-conserving surgery in a patient with a single ipsilateral chamber VVIR mode PM. No device failure or malfunction was reported for the PM before, during, or after the procedure. These findings support the use of targeted IORT for patients diagnosed with early-stage breast carcinomas who have a PM implanted. However, further research is needed to understand the safety of other methods and devices for IORT patients with cardiac implantable electronic devices. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |